2023-08-02 14:21:09 ET
- BioCryst Pharmaceuticals ( NASDAQ: BCRX ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.
- The consensus EPS Estimate is -$0.21 and the consensus Revenue Estimate is $81.43M (+24.3% Y/Y).
- Over the last 1 year, BCRX has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 2 downward. Revenue estimates have seen 5 upward revisions and 4 downward.
For further details see:
BioCryst Pharmaceuticals Q2 2023 Earnings Preview